Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Apollo Hospitals EnterpriseBOM:508869 -1.56%92 Return-on-Tangible-Equity is 25.79% as of Mar. 2026, which is 60% above its 10-year median of 16.07. GuruFocus rates BOM:508869 with a GF Score™ of 92/100 and a GF Value™ of ₹8,863.73 (Fairly Valued). The stock has 4 warning signs investors should review. Among 575 Healthcare Providers & Services companies, Apollo Hospitals Enterprise ranks better than 73.39% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Apollo Hospitals Enterprise's annualized net income for the quarter that ended in Mar. 2026 was ₹21,172 Mil. Apollo Hospitals Enterprise's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹82,084 Mil. Therefore, Apollo Hospitals Enterprise's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 25.79%.
The historical rank and industry rank for Apollo Hospitals Enterprise's Return-on-Tangible-Equity or its related term are showing as below:
BOM:508869'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 4.14 Med: 16.07 Max: 25.72
Current: 25.44
During the past 13 years, Apollo Hospitals Enterprise's highest Return-on-Tangible-Equity was 25.72%. The lowest was 4.14%. And the median was 16.07%.
BOM:508869's Return-on-Tangible-Equity is ranked better than 73.39% of 575
companies
in the Healthcare Providers & Services industry
Industry Median: 10.56
vs BOM:508869: 25.44
Apollo Hospitals Enterprise (BOM:508869) Return-on-Tangible-Equity Explanation
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Apollo Hospitals Enterprise Return-on-Tangible-Equity Related Terms
Apollo Hospitals Enterprise Return-on-Tangible-Equity Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Apollo Hospitals Enterprise Return-on-Tangible-Equity Chart
BOM:508869 vs HCA, THC, DVA: Return-on-Tangible-Equity Comparison
For the Medical Care Facilities subindustry, Apollo Hospitals Enterprise's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Apollo Hospitals Enterprise Return-on-Tangible-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Apollo Hospitals Enterprise's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Apollo Hospitals Enterprise's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 25.79% mean?
Apollo Hospitals Enterprise (BOM:508869) has a Return-on-Tangible-Equity of 25.79% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Apollo Hospitals Enterprise and its competitors. This is 60% above median its historical median of 16.07. Over the past decade, Apollo Hospitals Enterprise's Return-on-Tangible-Equity has ranged from 4.14 to 25.72. According to the industry distribution chart, Apollo Hospitals Enterprise ranks #153 out of 575 companies in the Healthcare Providers & Services industry, placing it in the top 26.6%.
Is Apollo Hospitals Enterprise's Return-on-Tangible-Equity too high?
Apollo Hospitals Enterprise's current Return-on-Tangible-Equity of 25.79% is 60% above median its 10-year median of 16.07. Over the past 10 years, this metric has ranged from a low of 4.14 to a high of 25.72. The Healthcare Providers & Services industry median Return-on-Tangible-Equity is 10.56. Apollo Hospitals Enterprise's value of 25.79% is 144.2% above this industry median. Based on the distribution chart, Apollo Hospitals Enterprise ranks #153 out of 575 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Apollo Hospitals Enterprise has a GF Score™ of 92/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Apollo Hospitals Enterprise's Return-on-Tangible-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Apollo Hospitals Enterprise ranks #153 out of 575 companies for Return-on-Tangible-Equity. This puts Apollo Hospitals Enterprise in the upper half of its industry. The industry median Return-on-Tangible-Equity is 10.56. Apollo Hospitals Enterprise's value of 25.79% is 144.2% above this benchmark. Historically, Apollo Hospitals Enterprise's own Return-on-Tangible-Equity has ranged from 4.14 to 25.72 over the past decade. While the company's 10-year median is 16.07 vs. the industry median of 10.56, Apollo Hospitals Enterprise has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Healthcare Providers & Services company?
The median Return-on-Tangible-Equity among Healthcare Providers & Services companies is 10.56, based on 575 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Apollo Hospitals Enterprise's current Return-on-Tangible-Equity of 25.79% is 144.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Apollo Hospitals Enterprise and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Equity is 10.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Apollo Hospitals Enterprise's current Return-on-Tangible-Equity is 25.79%, which is 60% above median its own 10-year median of 16.07. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apollo Hospitals Enterprise stock overvalued right now?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise (BOM:508869) is currently considered Fairly Valued. The stock's GF Value™ is ₹8,863.73, compared to a current price of ₹8,820.00 — trading 0.5% below its estimated fair value. The current Return-on-Tangible-Equity is 25.79%, which is 60% above median its 10-year median of 16.07 and 144.2% above the Healthcare Providers & Services industry median of 10.56. Apollo Hospitals Enterprise's overall GF Score™ is 92/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Apollo Hospitals Enterprise (BOM:508869), the current Return-on-Tangible-Equity is 25.79% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Apollo Hospitals Enterprise (BOM:508869) Overvalued in 2026?
Based on GuruFocus' analysis, Apollo Hospitals Enterprise stock appears to be undervalued.
The current stock price of ₹8,820.00 is trading 0.5% below its estimated GF Value™ of ₹8,863.73.
GuruFocus considers Apollo Hospitals Enterprise to be Fairly Valued.
Key valuation signals for BOM:508869:
Return-on-Tangible-Equity: 25.79% (60% above median its 10-year median of 16.07)
GF Value™: ₹8,863.73 vs. price of ₹8,820.00 (0.5% below fair value)
Industry Position: 144.2% above the Healthcare Providers & Services median (#153 of 575)
No single metric tells the full story. See the BOM:508869 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Apollo Hospitals Enterprise Ltd operates a network of private hospitals in India through primary, secondary, and tertiary care facilities. The firm's tertiary care hospitals provide complex care in a variety of specialties that include cardiology, oncology, neuroscience, orthopedics, radiology, and gastroenterology. Apollo Hospitals also operates primary care and diagnostics clinics as well as telemedicine units and offers consulting, health insurance, education and training, and research services. Its reportable operating segments are; Healthcare Services (represents hospitals and hospitals services); Retail Health and Diagnostics (includes clinics and diagnostics); Digital Health and Pharmacy Distribution; and Others. Maximum revenue is generated from its Healthcare Services segment.
92GF Score
Get the complete analysis for BOM:508869
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:508869 has been successfully added to your 
